论文部分内容阅读
1998年5月～2002年5月,我们采用大剂量黄芪注射液联合胸腺肽治疗慢性乙型肝炎98例,取得满意的临床效果,现报告如下。 病例选择:本组慢性乙型肝210例均为我科住院病人。诊断标准符合1995年第5次全国传染病和寄生虫病学术会议修订标准,其中慢性轻度50例,慢性中度120例,慢性重度40例。将以上病例随机分为两组:治疗组98例,男66例,女32例,年龄21～63岁,平均42.5岁;对照组112例,男86例,女26例,年龄18～64岁,平均41.6岁,全部病例肝功能异常,均为乙型肝炎病毒感染。 治疗方法:治疗组:黄芪注射液50ml,胸腺肽100mg分别
May 1998 to May 2002, we use high-dose Astragalus injection combined thymosin in the treatment of chronic hepatitis B in 98 cases, and achieved satisfactory clinical results, are as follows. Case selection: 210 cases of chronic hepatitis B in our hospital inpatients. Diagnostic criteria in line with the 1995 Fifth National Conference on Infectious Diseases and Parasitic Diseases revised standards, including 50 cases of chronic mild, moderate chronic 120 cases, 40 cases of chronic severe. The above cases were randomly divided into two groups: the treatment group 98 cases, 66 males and 32 females, aged 21 to 63 years, mean 42.5 years; control group of 112 patients, 86 males and 26 females, aged 18 to 64 years , An average of 41.6 years old, all cases of abnormal liver function, are Hepatitis B virus infection. Treatment: treatment group: astragalus injection 50ml, thymosin 100mg respectively